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1203-133 Predictors of Early Permanent Pacemaker Implantation 
Following Aortic Valve Replacement 
Sam Dawkins, Paul R. Kalra. Rakesh Sharma, Jim L. Monre, Keith D. Dawkins, Wessex 
Cardiac Unit, Southampton, United Kingdom, National Heart Lung Institute, London, 
United Kingdom. 
Background: Defects of the conducting system are common in patients with aortic valve 
disease. Aortic valve replacement (AVR) may result in the development of further con- 
duction abnormalities and necessitate permanent pacemaker implantation (PPM). We 
sought to identify predictors of early post-operative PPM in patients undergoing AVR. 
Methods: We assessed 354 consecutive patients undergoing AVR at a tertiary cardiac 
unit between January 1999 and July 2000. Data were incomplete in 4 patients and a fur- 
ther 8 had a pre-operative PPM Results for the remaining 342 (97%) patients are pre- 
sented (212 males, age 67±14 years, mean±SD). The mean length of patient follow-up 
was 114±192 days (range 2 to 938 days). The major indications for AVR were significant 
valvular stenosis (n=224), regurgitation (An, n=70), or infective endocarditis (n=25). The 
majority of procedures were elective (90%) and only one was a redo. Pre-operative con- 
ducting system disease, as determined from the resting electrocardiogram (first degree 
heart block, left or right bundle branch block, left anterior hemi-block), was present in 
26% of patients. 
Results: Post-operatively 29 (8.5%) patients required PPM Receiver operating charac- 
teristic (ROC) analysis demonstrated that the best cut-off vatue of aortic valve diameter 
(AVD) for predicting PPM requirement was 24mm (area under curve=0.60, 95% CI 0.55 
to 0.65). 13% of patients with an AVD >24ram required a PPM as compared to 6% of 
those with an AVD -<24mm (p=0.03). Patients with AR as an indication for surgery were 
more likely to require a P.PM as opposed to those without (16% vs 7%, p=0.01). Signifi- 
cantly more patients with pre-operative conducting system disease needed PPM (16% vs 
6%, p<0.01). 
Conclusions: The implantation of PPM following AVR is a relatively common occur- 
rence, and should be discussed with the patient as part of the preoperative consent pro- 
cess. We found that a large AVD, pre-operativo An, and pre-existing conducting disease 
were all significant predictors of PPM requirement. 
1203-134 Cryoab la t ion  at the Anatomically Determined Annular 
Site Prevents Myocardial Ischemia in Surgery for Atrial 
Fibrillation 
Haiime Imura. Takashi Nitta, Sekoh Suzuki, Daisuke Okeda, Kiyomi Yamada, Shigeo 
Yamauchi, Shigeo Tanaka, Nippon Medical School, Tokyo, Japan. 
Background The cryoablation at the mitral annulus is an essential procedure, which 
eliminates the reentry around the annulus, in the surgery for atrial fibrillation (AF). How- 
ever, postoperative myocardial ischemia has been recognized as a consequence of cor- 
onary injury from this procedure. We have previously shown, in autopsied hearts, that 
there was a no-coronary area (NCA) in the posterior mitral annulus, which proposed as 
the appropriate site for annular cryoablation, and this area was between 1.0 to 1.5 cm 
from the mid portion towards the posterior commissure in most of the hearts, in this 
study, we sought to determine whether cryoablation at NCA area prevents myocardial 
ischemia in patients undergoing surgery for AE 
Methods Forty-two patients who underwent mitral valve surgery with (N=32) or without 
(control, N=10) surgery for AF were examined in terms of the ischemic changes 
observed from the postoperative ECG, peak CPK-MB, and myocardial perfusion defects 
detected by resonance imaging (RI) using TI-CL During the surgery for AF, cryoablation 
was applied to the mid portion of the posterior mitral annulus (ordinary position) in 22 
patients (group 1) and to NCA area of the posterior annulus in 10 patients (group 2). 
Other procedures in AF surgery included multiple atrial incisions and isolation of the pul- 
monary veins. 
Results There was no mortality in each group. Postoperative peak CPK*MB was signifi- 
cantly higher (p<0.05) in AF surgery groups (group 1: 167±66, group 2:172±58 IU/ml) 
than in the control group (55±21 IU/ml). Ten patients (45%) in group 1 revealed new ST 
change or Q wave in the lateral and/or inferior left ventricular regions in the postoperative 
ECG, while this was observed in none of the control group or group 2 patients. These 
ischemic changes lasted for at least 2 weeks after surgery. Pertusion defects in the lat- 
eral and/or inferior area were confirmed in six of ten patients with ECG change on RI 
exam. 
Conclusion Postoperative iscehmic changes on ECG and Ri were not rare after AF 
operation. Cryoablation should be applied at no-coronary area (1.0-1.5 cm from the mid 
portion to the posterior commissure) on the posterior mitral annulus to prevent myocar- 
dial ischemia in surgery for AF. 
1203-135 L ip ids  in Pat ients  With Aor t i c  Valve Replacement: 
Impact of Preoperative Cholesterol Levels on the 
Embolization After Bileaflet Mechanical Valve 
Replacement 
Georo Nollert, Sonja Schrepfer, Tobias Deuse, Bruno Reichart, Department of Cardiac 
Surge~ University of Munich, Munich, German~ 
Background: Recent studies demonstrated the influence of cholesterol levels on embo- 
lization patterns in patients with carotid artery stenoses. We hypothesised that high lipid 
levels in patients after aortic valve replacement with a mechanical valve prosthesis may 
act as a cofactor for thromboemboli formation and may increase the risk of embolic 
events. 
Methods: Between November 1990 and September 1996 167 Patients underwent iso- 
lated aortic valve replacement with a Sorin Bicarbon mechanical valve prosthesis as a 
part of a prospective observational study. Follow-up consisted of a written questionnaire 
and visits at our clinic at 0.5, 1, and 8.5 ± 1.4 years. In order to calculate the influence of 
preoperative lipid levels on the embolization rate patients were split into quartiles accord- 
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ing to their preoperative LDL-cholesterel, cholesterol and triglycedde levels. Anticoagula- 
lion with coumarine was strictly maintained in all patients between INR 2 and 3. 
Results: During the first 5 years after operation, a total of 9 embolic strokes were 
recorded 62 to 91 months (mean: 71.1 ± 10.9 months) postoperatively. Patients with 
embolic events had higher preoperative LDL-tevels (170 ± 34 mg/dl vs. 139 ± 4 mg/dl; 
p=0.039) and cholesterol (244 ± 47 mg/dl vs. 194 ± 56 mg]dl; p=0.015) than those with- 
out embolic events. The Log-rank test (Kaplan-Meier analysis) revealed significantly 
more embotic events in the highest than the lowest quartile of preoperative LDL- and 
cholesterol-levels, respectively (4 vs. 0 and 5 vs. 0; p<O.05). Triglycedde-levels (154 ± 47 
mg/dl vs. 167 ± 122 mg/dl; p=0.52) did not differ between the groups. 
Conclusion: This study demonstrates that high LDL and total cholesterol levels may act 
as a cofactor besides insufficient anticoagulation in the formation of thromboemboli in 
patients after mechanical valve replacement. Postoperative Cholesterol lowering therapy 
may be a new and innovative approach to reduce the risk of embolism. 
1203-13(~ Str ict  Contro l  of  Blood Pressure May Have Beneficel 
Effects on Regression of Left Ventricular Hypertrophy 
After Aortic Valve Replacement for Pure Aortic Stenoeis 
Kazuhito Imanaka. Osami Kohmoto, Shigeyuki Nishimura, Yuji Yokote, Shunei Kyo, 
Saifama Medical School, Iruma-gun, Saitama, Japan. 
Background: Left ventricular hypertrophy (LVH) usuaUy sustains to some extent after aor- 
tic valve replacement (AVR). This is probably due to significant pressure gradient through 
prosthetic valve, sustained hypertension and/or irreversible myocardial changes. Meth- 
ods: To investigate if strict anti-hypertensive treatment may accelerate the regression of 
LVH, 76 cases of AVR for pure aortic stensosis were assigned into two groups: (1) strict 
anti-hypertensive treatment (target systolic blood pressure =120mmHg, n=38), conven- 
tional treatment (target systolic blood pressure =135mmHg, n=38). To achieve target 
blood pressure, we used diuretics, ACE inhibitors, beta-blockers, calcium channel block- 
ers or in combination. Background parameters including age, sex, aortic valve area, and 
left ventricular ejection fraction, pre-operative left ventricutar mass (LVM) were matched 
between two groups. LVM was calculated according to the Devereux formula from serial 
echocardiography. Results: LVM was significantly lower in strict anti-hypertensive treat- 
ment group than in conventional treatment group at 6 month and maintained at 12 month 
after AVR. There were no significant differences in pressure gradients through prosthetic 
valve, and left ventricular ejection fraction between two groups. LVM was not dependent 
on different classes of anti-hypertensive agents. Conclusion: Strict blood pressure con- 
trol was effective at reducing LVM after AVR for pure AS. 
mean±sd, *= P<O.O6 vs conventional treatment 
Systolic BP at 6 LVM before LVM at 6 LVM at 12 
months AVR months months 
Strict BP control 120±10mmHg* 372±126g NS 214±82g * 213±74g* 
Conventional BP Control 139±11mmHg 365±135g 264±101g 273±93g 
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893-1 A Load Adjusted Performance Index Enhances 
Prediction of Temporal Changes in Left Ventricular 
Ejection Fraction Among Asymptomatic Patients With 
Chronic Noniachemic Aortic Regurgitation and Initially 
Normal Resting Function 
Phyllis G. Suoing, Jeffrey S. Borer, Clare A. Hochreiter, Edmund M. Herrold, Mary J. 
Roman, Richard B. Devereux, Paul Kligfield, Wei/I Medical College of Cornel/Universi~ 
New York, New York. 
Background: We have shown that wall stress-adjusted change (6) in LV ejection fraction 
(EF) from rest to exercise (SLVEF-$ESS) efficiently predicts future heart failure, subnl 
LVEFrest and sudden death among asymptomatic pts with chronic severe aortic regurgi- 
tation (An) and baseline nl LVEFrest. However, corollary prediction of LVEFrest change 
rate has not been assessed. Methods: Therefore, among 77 asymptomatic unoperatad 
pts with chronic severe AR and nl LVEFrest at study entry (avg age 45±15yrs, 77% male), 
we determined the rate of change in radionuclide cineangiographic LVEFrest during 7±4 
yr annual study and tested the hypothesis that 5LVEF-,SESS has greater predictive value 
for this change than baseline LVEFrest, LYEFexercise, LVEFrest to exercise (unadjusted for 
,~ESS), echocardiographic LV internal dimensions (ID) in diastole, systole, tractional 
shortening, or age, gender, or disease etiology. Results: Avg change in LVEFrest was - 
0.1±1.0%/yr, but was >-1%/yr in 11 pts (max:[-3.1%/yr]). Though baseline LVIDdiasto~e 
(p=.02), 8 LVEFrest to exercise (unadjusted for ~ESS, p=.01), and ~LVEF-~ESS (p=.0t) 
each predicted temporal change in LVEFrest in univariate analysis, onty 8LVEF-JESS 
independently predicted this change in multivariate analysis (p=.009). In contrast, neither 
baseline LVIDsystole, fractional shortening, LVEFrest , LVEFexercise , nor clinical variables 
provided significant predictive information for LVEFrest change over time. Conclusion: 
Temporal change in LVEFrest generally is slow among pts with chronic severe An. How- 
ever, some pts progress relatively rapidly toward subnl LYEFrest, an accepted indicator of 
high prognostic risk without operation. These data support the value of load adjustment 
of 6LVEF for identifying pts at greatest risk of prognostically important deterioration in 
LVEFrest in An. 
